RhumbLine Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
67,900
-2,732
| -4% | -$42.2K | ﹤0.01% | 2218 |
|
|
2025
Q1 | $1.05M | Sell |
70,632
-3,905
| -5% | -$58.1K | ﹤0.01% | 2150 |
|
|
2024
Q4 | $987K | Buy |
74,537
+188
| +0.3% | +$2.49K | ﹤0.01% | 2255 |
|
|
2024
Q3 | $1.06M | Hold |
74,349
| – | – | ﹤0.01% | 2240 |
|
|
2024
Q2 | $962K | Buy |
74,349
+6,303
| +9% | +$81.6K | ﹤0.01% | 2268 |
|
|
2024
Q1 | $945K | Buy |
68,046
+10,420
| +18% | +$145K | ﹤0.01% | 2283 |
|
|
2023
Q4 | $822K | Sell |
57,626
-265
| -0.5% | -$3.78K | ﹤0.01% | 2374 |
|
|
2023
Q3 | $896K | Buy |
57,891
+575
| +1% | +$8.9K | ﹤0.01% | 2271 |
|
|
2023
Q2 | $900K | Buy |
+57,316
| New | +$900K | ﹤0.01% | 2351 |
|
|
2021
Q1 | – | Sell |
-15,036
| Closed | -$274K | – | 3027 |
|
|
2020
Q4 | $274K | Buy |
15,036
+3,770
| +33% | +$68.7K | ﹤0.01% | 2705 |
|
|
2020
Q3 | $201K | Buy |
+11,266
| New | +$201K | ﹤0.01% | 2687 |
|